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Abstract  
Human mesenchymal stem cell (hMSC) therapies have the potential to revolutionise the health- care industry 
and replicate the success of the therapeutic protein industry; however, for this to be achieved there is a need to 
apply key bioprocessing engineering principles and adopt a quantitative approach for large-scale 
reproducible hMSC bioprocess development.  Here we provide a quantitative analysis of the changes in 
concentration of glucose, lactate and ammonium with time during hMSC monolayer culture over 4 passages, 
under 100% and 20% dissolved oxgen (dO2), where either a 100%, 50% or 0% growth medium exchange 
was performed after 72h in culture. Yield coefficients, specific growth rates (h–1) and doubling times (h) 
were calculated for all cases. The 100% dO2 flasks outperformed the 20% dO2 flasks with respect to 
cumulative cell number, with the latter consuming more glucose and producing more lactate and 
ammonium. Further- more, the 100% and 50% medium exchange conditions resulted in similar cumulative 
cell num- bers, whilst the 0% conditions were significantly lower. Cell immunophenotype and multipotency 
were not affected by the experimental culture conditions. This study demonstrates the importance of 
determining optimal culture conditions for hMSC expansion and highlights a potential cost savings from 
only making a 50% medium exchange, which may prove significant for large-scale bioprocessing.   
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1. Introduction 
The next healthcare revolution will apply regenerative medicines; creating cell based biological 
therapies or biological substitutes for the replacement or restoration of tissue function lost through 
failure or disease [1]. Human mesenchymal stem cells (hMSCs) have been considered as a potential 
cell source for regenerative medicine applications and offer a number of advantages when compared 
to other cell types including their relative ease of isolation, multipotency, high in vitro expansion 
potential, established therapeutic efficacy, acceptability ethically and low immunogenicity [2, 3].  
However, whilst science has revealed the potential of such therapies and early adult stem cell-based 
products have shown their power [4], there is now a need for the long term supply of adult stem cells, 
including hMSCs, in sufficient numbers to create reproducible and cost effective therapeutic products. 
Whilst many of the challenges that lie ahead are biological, others lie under the largely untapped remit 
of the engineer. 
As with the therapeutic protein industry, measure- ment  and  control of culture  parameters is 
crucial,  with even small changes in culture conditions having a poten- tially  significant   effect.   
Currently,   the   expansion  of hMSCs typically involves the in vitro culture of cells as a 
monolayer in T-flasks under static conditions, with measurements usually limited to cell viability, 
confluency and those related to post-culture functionality.  However, it is our contention that  in 
order  to inform the  basis  of the development of the larger scale production of hMSCs, the 
factors  controlling  the  process  need  to be  fully under- stood by the engineer. A key analytical 
tool used in engineering  is the principle  of mass  balance  [5]. However, it has not been  possible  
to develop an accurate mass  balance  calculation   for hMSC  T-flask culture  as  nutrient usage,  
metabolite  production and  headspace gas  com- position are not routinely measured. It is, 
however, widely accepted that,  for mammalian cells used  in the  pro- duction  of heterologous 
recombinant proteins (e.g. CHO, HEK, etc.),  glucose   and  glutamine  are  vital  nutrient 
sources  for the generation of adenosine 5’-triphosphate (ATP) and the reduced form of 
nicotinamide adenine din- ucleotide  phosphate (NADPH), with  glucose  being utilised either 
by oxidative phosphorylation or via the process of anaerobic glycolysis [6]. A priori, adequate 
lev- els of glucose and glutamine are probably critical for the growth of hMSCs in vitro to avoid 
nutrient supply being rate-limiting. Likewise, it has been  established that  the cellular 
metabolism of glucose  and  glutamine results  in the production of toxic metabolites, such  as 
ammonium and  lactate,  which  are  secreted into  the  medium  and inhibit  cell growth.  Thus, 
the combination of an insufficient  nutrient supply  as  well  as  the  accumulation  of waste  
products in the  medium  can  have  a significant effect on cell growth rate, viability [6] and in 
the case of cells used for therapeutic purposes, their future functionality. 
In conventional mammalian cell culture,  the  level of dissolved oxygen (dO2) in the growth 
medium is also important and as such is always measured and often carefully  controlled.   
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Unfortunately,   there    is   a   disparity between the nomenclature used  to describe the oxygen 
concentration present in the cells’ growth medium  in the bioprocess   engineering and  life 
sciences fields,  which may lead to confusion when trying to understand the significance  of 
results.  With so much  experience already available  concerning the  growth  of animal  cells on 
the large scale, it would seem advantageous to bring the two into line. The levels of oxygen  
usually described by the term “normoxia” (20–21% v/v oxygen in the headspace) is equivalent 
to 100% dO2 in the culture medium  when saturated   with  respect to  air;  whilst  the  term  
“hypoxia” (2–5% v/v oxygen) is equivalent to 10–25% dO2. The problem is further exacerbated 
because when compared to the dO2 that hMSCs experience in the body (discussed later), 100% 
dO2  (“normoxia”) would generally be considered “hyperoxic” physiologically, whilst a reduced 
dO2 is more likely to be “normoxic” physiologically. Therefore by considering  the oxygen 
concentration in terms  of the nominal % dO2 with respect to saturation in the liquid medium, 
which is the standard nomenclature in biochemical  engi neering,  some of these  ambiguities can 
be reduced. 
 
A  review  of free-suspension animal  cell  culture  in large-scale  bioreactors indicated that they 
were typically controlled  at ~ 50% dO2, though  the  actual  value varied from process  to 
process.  On the other hand,  satisfactory performance with  some cell lines had  been  observed  
at the bench-scale with anywhere from 5% to 100% saturation [7]. However, the literature did 
not noticeably refer back to the cells’ origin when  selecting the  value used. The dO2 
concentration in the bone microenvironment within the body has been  mathematically 
modelled and shown  to be in equilibrium  with a range  of between 1% and 6% saturation [8, 9]. 
Recently, it has been shown that the oxygen concentration in the incubator in which the T-
flasks are contained has a significant effect on the expansion of hMSCs. The most commonly 
held belief is that the oxygen concentration experienced by the cells in the growth medium 
should mimic the in vivo physiological conditions from which the hMSCs have been derived, in 
this case, bone marrow. However, there are conflicting results.  Work has shown  [10–12] that  
under  “normoxic” conditions (i.e. 20% O2 / 75% N2, 5% CO2 v/v in the incubator, nominally 
≡100% dO2), the expansion of hMSCs is inferior to that obtained under so-called “hypoxic” 
conditions (~ 2-5% O2 v/v in the incubator, nominally ≡ 10–25% dO2). Other studies, however,  
have  demonstrated that, based  on the concentration in the incubator, 10–25% dO2 (“hypoxia”) 
can have an impact  on either  cell quality by attenuating cell differentiation   [13] or cell 
quantity  by reducing cell proliferation [14] in comparison to 100% dO2 (“normoxia”). However it 
should be pointed out in passing that the hMSCs used in the study by Holzwarth et al. [14] were 
obtained from bone marrow  aspirates of children with haematopoietic malignancies, although  
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the authors do not attribute the effects of lower oxygen tensions to the patients’ condition.  
Clearly, the problem is not yet fully resolved and there are a number  of possible explanations for 
this difference, not the least of which may be cell line specificity or culture conditions. 
Therefore, this  work sets  out  to thoroughly  characterise the standard manual T-flask 
process for the manual expansion of hMSCs in the laboratory and seeks to establish the likely key 
process engineering parameters for subsequent bioprocess  development. Indeed, this is the 
approach that was taken by the pharmaceutical industry more than two decades ago to develop 
large-scale  mammalian cell fermentation for the manufacture of therapeu- tic recombinant 
proteins  [5, 15, 16]. Here, two series  of experiments were undertaken at different oxygen 
concentrations (initial incubator gas  concentrations giving 100% dO2 and 20% dO2 in the 
culture medium  at saturation, hereafter  referred to as 100% dO2 and 20% dO2) and medium  
exchange protocols  (100%, 50% and  0%) after 72 h of in vitro culture of hMSCs over 4 
consecutive pas- sages.  Unfortunately, as with much of the earlier work in the   literature,   
because of equipment  limitations,   the change of oxygen concentration in the actual  T-flask 
headspace and medium  over time could not be tracked. Initially, a brief study was also 
undertaken at 10% dO2 in the medium  at saturation, but performance with respect to cell yield 
was approximately  15% lower in comparison to that at 20% dO2 (data not shown), so that further 
exper iments at this much lower concentration were stopped. In all cases, specific growth rates 
and yield coefficients with respect to glucose were calculated. 
 
 
 
 
2. Materials and Methods 
2.1 Cell growth and conditions 
Human MSCs were isolated from bone-marrow aspirate donated by Lonza (Lonza, Cologne AG) 
which had been obtained from a single healthy donor after the patient provided informed consent. The 
local Ethical Committee approved the use of the sample for research.  Cells from passage 1 were 
cryopreserved at a density of 2 x 106 cells.ml-1 in 2 ml of 0.5% human serum albumin (v/v), 5 ml of 
dimethylsulphoxide and 93 ml of plasmalyte.  All experiments were carried out starting from passage 
2.  Cells were cultured in 25 ml Dulbecco’s Modified Eagle Medium (DMEM; Lonza, UK) 
supplemented with 10% (v/v) foetal bovine serum (FBS; Hyclone, Lot# RUF35869) and 2 mM L-
glutamine (Lonza, UK).  Cells were grown in monolayer culture at 37oC in T75-flasks seeded at an 
initial density of 5000 cells.cm-2. Duplicate flasks were placed in an incubator with a controlled gas 
phase (New Brunswick Galaxy 170r incubator), firstly with air supplemented with 5% CO2 (here 
5 
 
called 100% dO2); and secondly with 5% CO2 and 4% O2 diluted with N2 (here called 20% dO2). The 
pH remained between 7.0 – 7.3 throughout the course of the investigation (determined by colorimetric 
visualisation of the phenol red containing medium and medium sample analysis). 
 
The growth medium was exchanged as appropriate (100%, 50% and 0%) after day 3 of the culture 
and cells were passaged at day 6 of culture (the usual time found by us for early-stage passage hMSCs 
to reach confluency). On passage, the hMSCs were washed with phosphate buffered saline (PBS; 
Lonza, UK) and then incubated for 4 min with trypsin (0.25%)/EDTA solution (Lonza, UK) to aid 
cell detachment from the culture plastic.  Trypsin was then inactivated by the addition of fresh growth 
medium equivalent to 3x the volume of the trypsin solution used for cell detachment. The cell 
suspension was then centrifuged at 220 g for 3 min at room temperature, the supernatant discarded 
and the remaining pellet re-suspended in an appropriate volume of culture medium. Viable cells were 
counted and an appropriate number of cells were then re-seeded to a fresh T-flask.  
 
A control condition was setup whereby duplicate T-flasks were left in the gas-phase controlled 
incubator for the full 6 days of culture.  This was done in order to compare the effect, if any, of 
oxygen concentration fluctuations in the medium arising from the removal of the T flask from the 
controlled environment of the incubator to atmospheric conditions for daily medium sampling.    
 
2.2 Analytical techniques 
A 1 ml sample was taken daily for analysis of pH, [glucose] g/L, [lactate] g/L, and [ammonium] 
mmol/L using a Nova Bioprofile FLEX (USA).  Cell counting and viability (via propidium iodide 
exclusion) was done using a NucleoCounter NC-100 automatic mammalian cell counter 
(Chemometec, Denmark).  Based on the viable cell number and metabolite data, the following 
parameters were determined:  
1. Specific Growth Rate: 𝜇 = �𝐿𝐿  �𝐶𝐶(𝑡)− 𝐶𝐶(0)��
∆𝑡
 
Where µ = specific growth rate (h-1), Cx(t) and Cx(0) = cell numbers at the end and start of 
exponential growth phase respectively and t = time (h)  
2. Doubling time:  𝑡𝑑 = 𝐿𝐿 2𝜇  
Where td = doubling time (h) and µ = specific growth rate (h-1) 
3. Population doubling = 3.32 ∗ �log  ( 𝐶𝐶(𝑡)
𝐶𝐶(0))� 
Where Cx(t) and Cx(0) = cell numbers at the end and start of exponential growth phase respectively 
and t = time (h) 
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4. Fold Increase  = 𝐶𝐶(𝑓)
𝐶𝐶(0) 
Where Cx(f) = final cell number at the end of passage and Cx(0) = initial cell number 
5. Specific metabolite consumption rate:  𝑞𝑚𝑚𝑡 = 𝜇𝐶𝐶(0) × 𝐶𝑚𝑚𝑚 (𝑚) −  𝐶𝑚𝑚𝑚  (0)𝑚𝜇𝑚− 1  
Where qmet = specific metabolite consumption rate, µ = specific growth rate (h-1), Cmet(t) and Cmet(0) = 
concentration of metabolite at the start and end of exponential growth phase respectively, Cx(0) = cell 
number at the start of exponential growth phase and t = time (h)  
6. Lactate yield from glucose: 𝑌𝐿𝐿𝐿/𝐺𝐺𝐿 = ∆[𝐿𝐿𝐿]∆[𝐺𝐺𝐿] 
Where YLac/Glc = lactate yield from glucose, ∆[Lac] = lactate production over specific time period and 
∆[Glc] = glucose consumption over same time period 
 
2. 3 Immunophenotypic analysis 
Immunophenotypic analysis of the hMSCs was determined by flow cytometry before and after hMSC 
expansion and was performed using a Beckman Coulter Quanta SC flow cytometer (Beckman 
Coulter, UK) with excitation at 488nm.  Cells were prepared for analysis by centrifuging at 300 g.  
The supernatant was discarded and the cells were resuspended in flow cytometry stain buffer (R&D 
Systems, UK).  A panel of mouse anti-human monoclonal antibodies was used to target cell-surface 
receptors and was prepared in accordance with the manufacturer’s instructions.  The antibodies 
selected were primarily in accordance with the Dominici et al. (2006) panel and included CD73-PE, 
CD105-PerCP, CD29-PE-Cy5, CD45-PE-Cy5, CD34-PE-Cy7 and HLA-DR-PE-Cy5 (BD 
Biosciences, UK).  Cells were incubated with the antibody in the dark at room temperature for 30 
min.  Associated isotype controls were also prepared for all experimental conditions.  A minimum of 
10,000 gated (Forward scatter/Side Scatter) events were recorded for each sample and the data was 
analysed using FlowJo computer software (Treestar Inc, USA). Flourescent gates were set above 95% 
of the isotype control. 
 
2.4 Multilineage potential  
The multi-lineage potential of the cells was ascertained by inducing the samples post-harvest with the 
StemPro Adipogenesis kit, StemPro Chondrogenesis kit and StemPro Osteogenesis kit.  
Differentiation media were prepared and used as per the manufacturer’s instructions.  Briefly, this 
involved thawing the supplement overnight and adding this to the basal differentiation medium.  Cells 
undergoing adipogenic or osteogenic differentiation were seeded onto a microwell plate at 5,000 
cells.cm-2 in growth medium and left in a humidified incubator at 37 °C, 5% CO2 for 3 days, after 
which the medium was replaced with specific differentiation medium and returned to the incubator.  
The medium was replaced every 3 days until day 21, at which point the hMSCs undergoing 
adipogenesis were stained with Oil Red O, and the hMSCs undergoing osteogenesis were stained with 
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alkaline phosphatase (ALP) and Von Kossa stains.  For chondrogenesis, a hMSC micromass would be 
formed by generating a cell suspension of 1.6 x 107 cells.mL-1 and then seeding 5 µL of this 
suspension onto microwells.  This would be placed into a humidified incubator at 37 °C, 5% CO2 for 
2 h, after which, chondrogenic medium would be added.  Chondrogenic medium was refreshed every 
72 h.   
 
After 21 days, all cell samples were stained with either alkaline phosphatase (ALP) and von Kossa 
staining (osteogenesis), 0.3% Oil Red O (adipogenesis) or Alcian Blue (chondrogenesis).  For 
adipogenic differentiation, the medium was aspirated and cells washed with PBS.  Cells were fixed 
with 2% (v/v) paraformaldehyde (PFA) for 30 min at room temperature.  Cells were then washed 
three times with PBS and 0.3% (w/v) Oil Red O solution was added and incubated at room 
temperature for 60 min.  Prior to observing under the microscope, the samples were washed with PBS 
three times and 1 mL distilled water was added.  Upon final washing, the samples were observed 
under a Nikon TS-100 light microscope (Nikon, UK). 
   
For chondrogenic differentiation, the medium was aspirated and washed with PBS.  The cells were 
fixed with 2% PFA for 1 min at room temperature.  Samples were then washed three times with PBS 
and 1% (w/v) Alcian Blue solution was added and kept at room temperature for 30 min.  Prior to 
observing under the microscope, the samples were washed with PBS three times and 1 mL distilled 
water was added.   
 
For osteogenic differentiation, the medium was aspirated and cells were washed with PBS.  The cells 
were fixed with 10% cold neutral-buffered formalin for 20 min at room temperature.  Samples were 
then washed with PBS and kept in distilled water for 15 min at room temperature before incubating 
with 4% (v/v) Napthol AS-MX phosphate alkaline solution in a darkened at room temperature for 45 
min.  Prior to observing under a microscope, samples were washed three times with distilled water.  
Distilled water was then removed and samples incubated with 2.5% (v/v) silver nitrate solution for 30 
min at room temperature.  The samples were then washed with distilled water three times before 
observing under a light microscope. 
 
3. Results and Discussion 
3. 1 Growth kinetics 
A series of experiments was carried out to evaluate the effect of oxygen concentration and medium 
exchange strategy on the culture of human bone marrow-derived mesenchymal stem cells (hMSCs). 
In all cases reproducible data were obtained as indicated by the tight error bars (Figures 1 and 2).   For 
the main programme of work, flasks were cultured for each medium exchange condition (100%, 50% 
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and 0% after day 3) and each oxygen concentration (nominally 100% dO2 and 20% dO2) over a period 
of 4 passages (576 h). During the culture period, daily medium samples were processed for metabolite 
analysis for all experimental conditions.  A control was also investigated to determine what effect, if 
any, the fluctuations in oxygen concentration arising from daily media sampling would have on the 
culture.  This was achieved by having duplicate T-flasks cultured at 20% dO2 which were not 
removed from this environment until day 6 of each passage.  hMSC expansion was monitored by 
measurement of viable cell number after each passage.  From this data, cumulative viable cell number 
and cumulative population doublings were calculated (Figure 1) for each set of conditions in addition 
to specific growth rate (h-1), fold increase and doubling time (h) (Figs. 3A, 3B and 3C). 
 
Before proceeding further, it is useful to consider the actual dissolved oxygen concentration in the 
medium in the T-flask since the number of cells consuming oxygen has been measured under different 
conditions. The oxygen concentration in the medium can be determined from the equation: 
NcellOc = kLA( *LC - CL) = kLA∆C    (7) 
where Ncell is number of cells in the T-flask (here up to about 3 x 106 cells.flask-1), Oc is the specific 
oxygen consumption rate of the cell, A is the medium/gas surface area in the T-flask (75 cm2), kL is the 
mass transfer coefficient and *LC and CL are the oxygen concentration in equilibrium with the head 
space gas and in the liquid phase respectively. Many of these parameters are not known precisely. 
However, sufficiently accurate estimates can be made to give an indication of how much the liquid 
phase oxygen concentration that the cells experience on the base of the T-flask is likely to fall due to 
their consumption of oxygen compared to that due to the concentration in the head space.  
 
An approximate specific oxygen uptake rate for the cells can be obtained from the work of Pattappa et 
al. [18] on human MSC cells as 9.8 x 10-11 mmol.cell-1.h-1 [15]; kL can be estimated from the work of 
Randers-Eichhorn et al. [19]. The latter found in T-flasks growing animal cells that the rate of oxygen 
transfer into the medium at depths of 4 mm or less was essentially governed by molecular diffusion, 
i.e., kL = D/x where D is the diffusivity of oxygen and x is the depth of medium above the cells, here 1 
mm. The diffusivity in the medium depends on both its composition and temperature.  The former is 
not known precisely but the sensitivity to water, salt and glucose solutions at 20 °C is rather weak 
[20]; and whilst the effect of temperature is quite substantial, the value at the cultivation temperature 
is not given [http://compost.css.cornell.edu/oxygen/oxygen.diff.water.html].  A value of 0.11 cm2.h-1 
is assumed based on the above references to give kL = 1.1 cm.h-1. Thus, from Eq 7, ∆C = 3.36 x 10-6 
mmol.cm-3 = 3.36 x 10-3 mmol.L-1. 
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Randers-Eichhorn et al. [19] also cultivated CHO cells in T-flasks to a cell density of  ~ 2 x 106 
cells.mL-1 in a 350 mL T-flask with a specific oxygen uptake rate of  ~ 1.3 x 10-10 mmol O2.cell-1.hr-1 
[16] (similar to values up to 2 x 10-10 mmol O2.cell-1.hr-1 found by Miller et al. (1988) [21]). Under 
these conditions, where the overall oxygen demand of the CHO cells will be much greater than in this 
work (and indeed significant oxygen depletion was measured in the medium), they found that the 
head space oxygen concentration was essentially constant and equal to that in the incubator whether 
the T flask caps were cracked open or completely closed. It seems reasonable to assume here therefore 
that the headspace oxygen concentration in the T-flask was the same as in the incubator. It is assumed 
therefore that an atmospheric air concentration of ~20% O2 in the incubator will give the same 
concentration in the headspace of the T-flask and an equilibrium concentration in the media of ~ 0.2 
mmol.L-1 at 35 °C [22].  
Thus, even with assumptions made here, it is clear that since ∆CL = ~ 3.36 x 10-3 mmol.L-1 << *LC , 
the oxygen concentration in the medium at the base of the T-flask, CL (where the cells grow) will 
essentially be the same as that at the gas/medium interface, *LC , which is, by definition, in 
equilibrium with that in the headspace. Since the headspace and the incubator concentrations are the 
same too, it is therefore correct to call the concentration in the medium 100% or 20% dO2 for the two 
incubator oxygen concentrations used in this work.  
 
Differences with respect to cumulative viable cell number and population doublings were observed 
between each different dO2, with 100% dO2 yielding a greater number of viable cells for each medium 
condition than the 20% dO2.  Flasks cultured under 100% dO2 and subjected to a 100% medium 
exchange gave a cumulative total of greater than 12.5 x 106 viable cells over a period of four passages, 
whilst flasks subjected to the same medium exchange routine but cultured under 20% dO2 yielded a 
cumulative total of less than 10.0 x 106 cells.  This was similarly reflected with the 50% and 0% 
medium exchange conditions where the cumulative numbers of viable cells were higher when 
cultured under 100% dO2 as opposed to those cultured under 20% dO2.  As a result, the population 
doublings for the flasks cultured under the higher dO2 were also greater (12.2, 11.5, 9.7 population 
doublings for 100%, 50% and 0% medium exchange conditions respectively), than those cultured 
under the lower dO2 (11.5, 10.7 and 8.7 population doublings for 100%, 50% and 0% medium 
exchange conditions respectively).  The control flasks which remained in the 20% dO2 environment 
for the duration of each passage showed no significant difference in terms of viable cell number in 
comparison to the 0% medium exchange condition cultured at the 20% dO2 condition, i.e the cell 
yield values consistently fell within the range of the error bars for the 0% medium exchange at 20% 
dO2.  Importantly, this illustrates that variations in cell yield did not arise from any dO2 fluctuations in 
the medium as a result of daily sampling. Figure 1 also illustrates the effect of varying the percentage 
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medium exchange on cell yield, with the 100% medium exchange yielding the largest cumulative 
number of viable cells and population doublings in comparison to the 50% and 0% medium exchange 
conditions irrespective of the dO2 concentration. 
 
 In general, it was found that the specific growth rate, doubling time and fold increase mirrored the 
trends found with the cumulative viable cell number and population doubling data, with the 100% dO2 
and 100% medium exchange conditions having the greatest impact on cell yield and growth kinetics.  
The findings here are in agreement with others [14], who found that a lower dO2 tension restricted the 
proliferative capacity of hMSCs in comparison with hMSCs cultured at 20-21% v/v O2 in the gas 
phase (100% dO2).   Importantly, the results presented here are in contrast to other work [10, 23-25] 
suggesting improved hMSC proliferation kinetics when cultured under low dissolved oxygen 
conditions. It is likely that such differences are in part due to the innate donor-to-donor variability of 
cells, as well as differences in culture conditions [26], including, but not limited to, the use of 
different undefined, serum-based media and initial cell passage number.  Further, cell passage number 
can have a significant effect on hMSC quality [25] with respect to proliferation, phenotype and 
differentiation potential.  Indeed, such an effect can also be found from the data presented here where 
there is an overall decrease in the specific growth rate and an increase in the doubling times as 
passage number increases for all medium exchange and dO2 conditions (Fig 3).  Despite the cells 
being cultured over only four passages (passages 3-7 of actual cell age, identified as passages 1-4 in 
this investigation), the cell growth kinetics are affected and will only be further affected as passage 
number increases.  There were, however, no discernible effects on phenotype or differentiation 
potential (as discussed later). 
 
The data presented here raises valid questions regarding the optimal conditions for the expansion of 
hMSCs.  Many groups who have investigated the culture of hMSCs at lower oxygen concentrations, 
including Lavrentieva et al. 2010 [25] and Dos Santos et al. 2010 [24], have done so on the basis that 
such an environment is similar to that experienced by the hMSCs in vivo.  Whilst this is undisputed, it 
must also be recognised that in vivo, hMSCs account for few of the cells in the bone marrow niche, 
ranging from 1 in 10,000 marrow cells in a newborn to 1 in 100,000 for teens and 1 in 2,000,000 for 
those aged 80 [28].  From a bioprocessing perspective, the focus would firmly be on optimising 
culture conditions to ensure maximum expansion, whilst retaining critical to quality features.  
Therefore, it may be argued that replicating in vivo conditions with respect to oxygen concentration 
may not necessarily equate with the optimum conditions for hMSC expansion given that at the low 
oxygen concentrations within the bone marrow niche, there is a very small number of hMSCs present.  
It could also be suggested therefore that in vivo expansion of hMSCs does not occur in the hypoxic 
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environments of the bone marrow niche, but rather either en route or at the actual site of injury, which 
are likely to be under a higher oxygen concentration [29] than that of bone marrow.   
 
When looking at the effects of oxygen concentration on other stem cells types, just as in the MSC-
based literature, there is conflicting evidence about the impact of low oxygen conditions on the 
proliferation of adipose stem cells [30-32], hematopoietic stem cells and progenitor cells [33-39]. 
Indeed, the effect of low oxygen tension  on haematopoietic stem  and  progenitor  cells, which  
share the  same  bone  marrow  niche  as  hMSCs,  is an  area  of research that  has  been  
investigated over a number  of years, with studies dating  back to the 1970s [40, 41]. As early 
as 1986, conflicting  reports  were emerging regarding the effect of low oxygen concentration on 
these  cells [39]  in  that   all  colony  types   investigated  (CFU-mix, BFU-E, CFU-E, and  CFU-
GM) demonstrated enhanced growth at low oxygen conditions (5% O2) in comparison to 
atmospheric oxygen conditions [39]. In the same  year it was reported  that the growth of 
haematopoietic progenitor cells from cord blood was enhanced at a low oxygen concentration 
(5% O2) only for the early stage  of the culture (weeks 0-4) and that by week 5, the growth was 
supe- rior at atmospheric conditions [36]. Moreover, it was demonstrated that  at atmospheric 
conditions, CFU-GM were maintained for more than 12 weeks; in comparison, no CFU-GM 
were detected after week 8 at the low oxygen concentration [36]. In a similar study  but with the 
inclusion of an irradiated bone marrow stromal layer [38], it was reported that growth of 
haematopoietic stem and progenitor cells was superior in low oxygen conditions (5% O2) in 
comparison to atmospheric oxygen conditions, although the effects were not as pronounced 
[38]. Meanwhile it was found  [33] that  human  bone  marrow  derived  lin-CD34+ cells grown for 
4 days in low oxygen (1.5% O2 in the incubator) culture conditions exhibited a lower fold 
expansion (~ 3.8  fold)  compared  to  those   cultured   in  20%  O2, (~ 2.9    fold).   Indeed,    a    
specific    subpopulation   of lin–CD34+CD38– cells responded in the opposite  manner, with an 
approximately  2.5 fold expansion under  the low oxygen  conditions  compared  with  1.5  fold 
expansion under  atmospheric conditions, indicating that  some  of the conflicting data may be 
due to differences  in the cell populations studied [33]. 
Given  this  disparity  in  the  literature  regarding the effect  of low oxygen  concentration for 
haematopoietic, adipose  and mesenchymal stem cells, it is clear that further work is required  
to provide a definitive answer  as to the exact effect of oxygen concentration on the culture of 
such cell types. As suggested by others [42], a standardised  experimental approach would  
certainly  aid  in this endeavour and  would further  our understanding of how various stem  
cells respond  to a range  of oxygen concentrations  [42], as would attempts to mimic  the  stem  
cell niche  ex vivo, where  the  oxygen  concentration can  be configured to match  the 
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physiological concentration [23]. Furthermore, we  agree  with  the  attempts to  establish clear 
nomenclature with respect to oxygen concentrations both in vitro and in vivo as suggested by 
others [43,44], however  it is our contention that  the  pre-existing nomenclature in 
biochemical  engineering be employed where oxygen concentration is considered in terms of 
the nominal  % dO2  with  respect to saturation in the  liquid medium, thereby  reducing any 
ambiguity. 
Recently, the wealth  of studies on hypoxia, haematopoietic stem cells and the role of HIF 
expression in the cellular response to hypoxia have been extensively reviewed and we would 
direct the readers  to this work for more in- depth analysis [45]. Elsewhere it has been suggested 
that slow-cycling haematopoietic stem cells are more likely to remain in the  lower oxygen  areas  
of the  niche,  further away from local vasculature, whilst fast-cycling haematopoietic stem cells 
are more likely to remain closer to blood vessels  [29]. It is argued  that  this  may  prove  
advantageous  for the slow-cycling  haematopoietic stem  cells as they may avoid the effects of 
oxidative stress,  which can result  in DNA damage due  to the  formation  of reactive oxygen  
species [46]; this  hypothesis was  strengthened further when  it was found that  mouse  
embryonic  fibroblasts  cultured  at  atmospheric oxygen  conditions developed more mutations 
and senesced faster than those cultured at 3% oxygen conditions [47]. Whilst haematopoietic 
stem  cells are a different cell type than  bone  marrow MSCs, given that they share the bone 
marrow niche, it is interesting to note in passing that low oxygen concentrations are more 
favorable for slow-cycling haematopoietic stem cells than higher oxygen concentrations 
 
3.2 Metabolite analysis   
Reproducible measurements of key metabolites, glucose, lactate and ammonium, were obtained daily 
to ascertain the consumption of glucose and production of lactate and ammonium during culture 
(Figure 2).  In general, the concentration of glucose was lower and the concentrations of lactate and 
ammonium was greater by the end of the passage when no medium exchange was performed in 
comparison to flasks which had a 50% or 100% medium exchange after 72 h.  This effect was greater 
when the cells were cultured under 20% dO2.  The medium exchange in hMSC culture plays an 
important role in not only replenishing the cells with key nutrients such as glucose, but also serves to 
avoid accumulation of inhibitory waste products such as lactate and ammonium (Figure 2).  The lower 
cell yield obtained with the 0% medium exchange in comparison to the 50% and 100% medium 
exchange can therefore be attributed to the build up of inhibitory waste products and a lower glucose 
level, resulting in an effect on cell proliferation.   
 
All experimental conditions follow the same trend with respect to metabolite consumption/production 
and correlate with increasing cell number; the level of glucose decreases during culture whilst the 
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levels of ammonium and lactate increase (Figure 2).  The metabolite data, in conjunction with cell 
growth kinetics, allows for the calculation of the specific glucose consumption rate (pmol cell-1 day-1), 
specific lactate production rate (pmol cell-1 day-1) and yield of lactate from glucose (mol.mol-1) 
(Figures 3D, 3E and 3F).  When comparing the metabolite data for both dO2 conditions irrespective of 
medium exchange condition, it is evident that significantly more glucose is consumed whilst more 
lactate and ammonium is produced when cultured under 20% dO2 despite the 20% dO2 condition 
yielding fewer cells.  However the lactate and ammonium concentrations did not reach values which 
may be considered to inhibit cell growth, which have been determined experimentally for hMSCs as 
greater than 20 mmol/L and 2 mmol/L for ammonium respectively [48].  The increase in glucose 
consumed and lactate produced for cells cultured at 20% dO2 is reflected in the glucose consumption 
and lactate production rates where there is a consistent significant difference between the dO2 tensions 
for all medium exchange conditions (Figure 3).  These findings are consistent with in vitro studies 
investigating the effect of oxygen tension on hMSCs [24,25].  Despite contrasting results of dO2 on 
hMSC proliferation, there is similarity in the increased consumption of nutrients and increased 
production of inhibitory waste products.  The increase in consumption of glucose and production of 
ammonium and lactate indicate that there are cellular responses due to the stress of a low oxygen 
environment.  Such an environment initiates the usage of alternative intracellular pathways, thereby 
impacting cellular metabolism which may impact proliferation.  It is believed that under lower 
dissolved oxygen conditions, mammalian cells adapt by activating various cellular pathways 
including gene-regulation by so called “hypoxia”-inducible factors and mTOR signalling [49].  The 
intracellular responses to low oxygen-induced stress results in cell cycle arrest which can impact 
proliferation of hMSCs as the cells attempt to maintain homeostasis and enter a quiescent state [14].  
Despite the lower cell yields and increased glucose and lactate production rates, the cells cultured at 
both dissolved oxygen conditions generally gave values for yield of lactate from glucose (Ylactate/glucose) 
in excess of ~2 mol.mol-1.  Theoretically only ~ 2 mole of lactate can be obtained from each mole of 
glucose [32]. Therefore, a Ylactate/glucose value of >2 suggests lactate being acquired through the 
catabolism of other carbon sources, such as glutamine or other amino acids [6], which would appear 
to be the case for most of the experimental culture conditions studied here.   
 
 
 
3.3 Immunophenotype analysis 
In order to determine the quality of the hMSCs and to identify whether there had been any change 
following expansion under both dissolved oxygen tensions, immunophenotype analysis was 
performed using flow cytometry before the cells were seeded for passage 1 of the experiment and 
subsequently at the end of passage 4. For all experimental conditions both before and after the 
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investigation, > 95% of the cell population were positive for CD29, CD73 and CD105 (markers which 
are commonly associated with multi-potent hMSCs) and < 5% of the cell population were positive for 
CD45, CD34 and HLA-DR (markers used as negative controls) (Figure 4, Tables 1A and 1B).  As 
such, the effect of medium exchange and dO2 had no discernible effect on the immunophenotype of 
the hMSCs.  However, according to the ISCT’s criteria for defining hMSCs, >2% HLA-DR 
expression is indicative of an activated MSC population.  Our results indicate that before the first 
experimental passage (0 h), a small percentage of our MSC population (~4.5%) is activated, however, 
this value does not increase to 5% for any experimental culture condition after 4 passages. 
 
3.4 Multilineage potential 
The multilineage potential of the hMSCs was demonstrated by inducing differentiation towards the 
osteogenic, adipogenic and chondrogenic lineages.  After 14 days in lineage-specific differentiation 
media, samples of all experimental conditions were found to be positive for alkaline phosphatase and 
von Kossa staining demonstrating osteogenic differentiation capability; positive for Oil Red O 
staining demonstrating adipogenic differentiation capability and positive for Alcian Blue staining 
demonstrating chondrogenic differentiation capability (Figure 5).  As with the immunophenotypic 
analysis, the effect of medium exchange and dO2 did not affect the differentiation capacity of the 
hMSCs.      
4. Concluding remarks 
It is recognised that today, hMSC culture is at a crucial junction similar to that of CHO cell culture 
20-30 years ago.  Measurements taken during hMSC culture are usually restricted only to cell number, 
viability, confluency and those related to functionality.  To realise the potential of hMSC-based 
therapeutics, it is incumbent that, where possible, quantitative measurements are obtained to provide 
an accurate reflection of culture conditions and as a means for process engineering development (e.g. 
the accurate calculation of nutrient feed rates for perfusion culture).  Further, the data presented here 
raises valid questions regarding the optimal conditions for the expansion of hMSCs, given in vivo 
conditions (within the bone marrow niche), the oxygen concentration is considered “hypoxic”, yet it is 
recognised that there are very few hMSCs present [28].  
 
It was found that 20% dO2 impacts human MSC proliferation resulting in lower cell yields in 
comparison to hMSCs cultured under 100% dO2 conditions.  This is in contrast to other studies which 
demonstrate an increase in hMSC yield under lower oxygen concentrations and the hypothesis that 
hMSC proliferation would increase under physiologically similar dO2 levels.  That there is disparity in 
the literature with regards to the effect of oxygen concentration on hMSC proliferation highlights the 
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variability that exists between cell lines and is likely to be a result of donor-to-donor variability and/or 
medium formulation.     
 
The data also highlight the importance of implementing a quantitative approach and measuring as 
many parameters as possible in an attempt to understand internal cellular mechanisms and processes.  
Whilst the hMSC yield decreased at lower oxygen concentrations, the rate of glucose consumption 
and lactate and ammonium production increased, therefore suggesting different metabolic pathways 
being employed as the hMSCs adapt to low oxygen conditions.  The medium exchange quantity was 
found to also have an effect cell proliferation and metabolism, with a 100% medium exchange 
resulting in the greatest cumulative viable cell number over the series of four passages, followed by 
the 50% which was slightly lower and then, significantly lower, 0% respectively.  Based on the 
metabolite data, this is likely to be due to the accumulation of inhibitory concentrations of lactate and 
ammonium or other unknown waste products.  There was a clear correlation between the 
concentration of these known metabolites and the percentage of medium exchange performed, 
whereby the lower percentage of medium exchange performed, the higher the concentration of both 
ammonium and lactate at the end of each passage.  This demonstrates that where possible, a complete 
medium exchange would aid cell proliferation through the replacement of lost nutrients, and more 
importantly perhaps through the removal of inhibitory waste products. Indeed this would suggest the 
development of perfusion culture at the larger scale. Importantly, despite the variation in experimental 
conditions, there was no discernible effect on cell quality as the cells retained both their 
immunophenotype and multi-lineage differentiation capability throughout.   
Acknowledgements 
The authors would like to acknowledge the Biotechnology and Biological Sciences Research Council 
(BBSRC; UK) Bioprocessing Research Industries Club (BRIC), the Engineering and Physical 
Sciences Research Council (EPSRC; UK) and Lonza GmbH (Cologne, Germany) for their financial 
support. 
 
The authors declare no commercial or financial conflict of interest 
References 
 
[1] Hewitt, C. J., Lee, K., Nienow, A. W., Thomas, R. J. et al., Expansion of human  
mesenchymal stem  cells  on  microcarriers.  Biotechnol. Lett. 2011, 33, 2325–2335. 
[2] Baksh, D., Song, L., Tuan, R. S., Adult mesenchymal stem cells: characterization, 
differentiation,  and application in cell and gene therapy. J. Cell. Mol. Med. 2004, 8, 301–316. 
16 
 
[3] Jackson, L., Jones, D. R., Scotting, P., Sottile, V., Adult mesenchymal stem cells: 
differentiation  potential  and  therapeutic applications. J. Postgrad. Med. 2007, 53, 121–127. 
[4] Brindley, D., Mason, C., Human embryonic  stem cell therapy  in the post-Geron  era. Regen. 
Med. 2012, 7, 17–18. 
[5] Doran, P. M., Bioprocess  Engineering  Principles, Academic Press, San Diego 1995. 
[6] Glacken, M. W., Catabolic Control of Mammalian  Cell Culture. Nat. 
Biotech. 1988, 6, 1041–1050. 
[7] Nienow, A. W., Reactor engineering in large scale animal cell culture. 
Cytotechnology 2006, 50, 9–33. 
[8] Chow, D. C., Wenning, L. A., Miller, W. M., Papoutsakis, E. T., Modeling pO2 distributions 
in the bone marrow hematopoietic compartment. I. Krogh’s model. Biophys. J. 2001, 81, 675–
684. 
[9] Chow, D. C., Wenning, L. A., Miller, W. M., Papoutsakis, E. T., Modeling pO2  distributions 
in the bone marrow hematopoietic compartment. II. modified Kroghian models. Biophys. J. 
2001, 81, 685–696. 
[10] Grayson, W. L., Zhao, F., Bunnell, B., Ma, T., Hypoxia enhances proliferation and tissue  
formation of human  mesenchymal stem  cells. Biochem. Biophys. Res. Commun. 2007, 358, 
948–953. 
[11] Hung, S. P., Ho, J. H., Shih, Y. V., Lo, T., Lee, O. K., Hypoxia promotes proliferation and 
osteogenic differentiation  potentials of human mesenchymal stem cells. J. Orthop. Res. 
2012, 30, 260–266. 
[12] Estrada,  J. C., Albo, C., Benguría,  A., Dopazo, A. et al., Culture  of human  mesenchymal 
stem cells at low oxygen tension  improves growth and genetic stability by activating 
glycolysis. Cell Death Dif- fer. 2011, 19, 743–755. 
[13] Fehrer, C., Brunauer,  R., Laschober,  G., Unterluggauer, H. et al., Reduced   oxygen  tension   
attenuates  differentiation   capacity  of human  mesenchymal stem cells and prolongs their 
lifespan. Aging Cell 2007, 6, 745–757. 
[14] Holzwarth, C., Vaegler, M., Gieseke, F., Pfister, S. M. et al., Low physiologic oxygen  tensions 
reduce  proliferation  and  differentiation  of human multipotent mesenchymal stromal cells. 
BMC Cell Biol. 2010, 
11, 11. 
[15] Mason, C., Hoare, M., Regenerative medicine bioprocessing: the need to learn from the 
experience of other fields. Regen. Med. 2006, 
1, 615–623. 
[16] Jones,  S., McKee, S. D., Levine, H. L., Emerging  challenges  in cell therapy  manufacturing. 
Bioprocess Int. 2012, 10, 4–7. 
17 
 
[17] Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I. et al., Minimal  criteria   for  
defining   multipotent  mesenchymal  stromal cells. The International Society for Cellular 
Therapy  position  statement. Cytotherapy,  2006, 8, 315–7. 
[18] Pattappa, G., Heywood, H. K., de Bruijn, J. D., Lee, D. A., The metabolism of human 
mesenchymal stem cells during proliferation and differentiation.  J. Cell. Physiol. 2011, 226, 
2562–2570. 
[19] Randers-Eichhorn, L., Bartlett, R. A., Frey, D. D., Rao, G., Noninvasive oxygen 
measurements and mass transfer considerations in tissue culture flasks. Biotechnol. Bioeng. 
1996, 51, 466–478. 
[20] Jamnongwong, M., Loubiere, K., Dietrich, N., Hébrard,  G., Experimental  study  of oxygen  
diffusion coefficients  in clean  water  containing  salt, glucose or surfactant: Consequences 
on the liquid-side mass transfer coefficients. Chem. Eng. J. 2010, 165, 758–768. 
[21] Miller, W. M., Wilke, C. R., Blanch, H. W., Transient responses of hybridoma metabolism 
to changes in the oxygen supply rate in continuous  culture. Bioprocess Eng. 1988, 3, 103–111. 
[22] Bailey, J. E., Ollis, D. F., Biochemical  Engineering  Fundamentals, McGraw-Hill, New York 
1986. 
[23] Dellatore, S. M., Garcia,  A. S., Miller, W. M., Mimicking  stem  cell niches to increase stem 
cell expansion. Curr. Opin. Biotechnol. 2008, 
19, 534–540. 
[24] Dos Santos, F., Andrade, P. Z., Boura, J. S., Abecasis, M. M. et al., Ex vivo expansion of 
human  mesenchymal stem cells: a more effective cell proliferation kinetics  and metabolism 
under hypoxia. J. Cell. Physiol. 2010, 223, 27–35. 
[25] Lavrentieva,  A., Majore, I., Kasper, C., Hass, R., Effects of hypoxic culture  conditions on 
umbilical cord-derived human  mesenchymal stem cells. Cell Commun. Signal 2010, 8, 18. 
[26] Sotiropoulou,  P. A., Perez, S. A., Salagianni,  M., Baxevanis,  C. N., Papamichail, M., 
Characterization of the optimal culture conditions for clinical  scale  production of human  
mesenchymal stem  cells. Stem  Cells 2006, 24, 462–471. 
[27] Wagner, W., Horn, P., Castoldi, M., Diehlmann, A. et al., Replicative senescence of 
mesenchymal stem cells: a continuous and organized process.  PLoS ONE 2008, 3, e2213. 
[28] Caplan, A. I., Adult mesenchymal stem cells for tissue  engineering versus regenerative 
medicine. J. Cell. Physiol. 2007, 213, 341–347. 
[29] Mohyeldin, A., Garzon-Muvdi, T., Quinones-Hinojosa, A., Oxygen in stem  cell biology: a 
critical component of the stem  cell niche.  Cell Stem  Cell 2010, 7, 150–161. 
[30] Thangarajah, H., Vial, I. N., Chang, E., El-Ftesi, S. et al., IFATS collection:  adipose   stromal  
cells  adopt  a  proangiogenic phenotype under the influence of hypoxia. Stem  Cells 2009, 
27, 266–274. 
18 
 
[31] Follmar, K. E., Decroos, F. C., Prichard, H. L., Wang, H. T. et al., Effects of glutamine,  glucose, 
and oxygen concentration on the metabolism and  proliferation of rabbit  adipose-derived 
stem  cells. Tissue  Eng.2006, 12, 3525–3533. 
[32] Khan, W. S., Adesida,  A. B., Hardingham, T. E., Hypoxic conditions increase hypoxia-
inducible transcription factor 2alpha and enhance chondrogenesis in stem cells from the 
infrapatellar fat pad of osteoarthritis patients. Arthritis Res. Ther. 2007, 9, R55. 
[33] Danet,  G. H., Pan, Y., Luongo, J. L., Bonnet,  D. A., Simon, M. C., Expansion  of human  
SCID-repopulating  cells under hypoxic conditions. J. Clin. Invest. 2003, 112, 126–135. 
[34] Eliasson, P., Rehn, M., Hammar, P., Larsson, P. et al., Hypoxia mediates  low cell-cycle 
activity  and  increases the  proportion  of long- term–reconstituting hematopoietic stem  
cells during  in vitro cul- ture. Exp. Hematol. 2010, 38, 301–310.e302. 
[35] Ivanovic, Z., Dello Sbarba, P., Trimoreau, F., Faucher,  J. L., Praloran, V., Primitive human  
HPCs are better  maintained and expanded in vitro at  1 percent oxygen  than  at  20 
percent. Transfusion  (Paris)2000, 40, 1482–1488. 
[36] Smith, S., Broxmeyer, H. E., The influence of oxygen tension  on the long-term  growth  in 
vitro of haematopoietic progenitor  cells from human  cord blood. Br. J. Haematol. 1986, 63, 
29–34. 
[37] Koller, M. R., Bender, J. G., Miller, W. M., Papoutsakis, E. T., Reduced oxygen tension  
increases hematopoiesis in long-term  culture  of human  stem and progenitor cells from cord 
blood and bone marrow. Exp. Hematol. 1992, 20, 264–270. 
[38] Koller, M. R., Bender, J. G., Papoutsakis, E. T., Miller, W. M., Beneficial effects  of reduced 
oxygen  tension  and  perfusion  in long-term hematopoietic cultures.  Ann. N. Y. Acad. Sci. 
1992, 665, 105–116. 
[39] Maeda, H., Hotta, T., Yamada, H., Enhanced colony formation of human  hemopoietic stem 
cells in reduced oxygen tension.  Exp. Hematol. 1986, 14, 930–934. 
[40] Murphy, M. J., Jr., Lord, B. I., Hematopoietic stem cell regulation.  I. Acute  effects of 
hypoxic-hypoxia  on CFU kinetics.  Blood 1973, 42, 81–87. 
[41] Lord, B. I., Murphy, M. J., Jr., Hematopoietic stem cell regulation.  II. Chronic effects of 
hypoxic-hypoxia  on CFU kinetics.  Blood 1973, 42, 89–98. 
[42] Abdollahi, H., Harris, L. J., Zhang, P., McIlhenny, S. et al., The role of hypoxia in stem  cell 
differentiation  and therapeutics. J. Surg. Res.2011, 165, 112–117. 
[43] Ivanovic, Z., Hypoxia or in situ normoxia: The stem  cell paradigm. J. Cell. Physiol. 2009, 
219, 271–275. 
[44] Guitart, A. V., Hammoud, M., Dello Sbarba, P., Ivanovic, Z., Praloran, V., Slow-
cycling/quiescence balance  of hematopoietic stem cells is related to physiological gradient 
of oxygen. Exp. Hematol. 2010, 38, 
19 
 
847–851. 
[45] Eliasson, P., Jonsson, J. I., The hematopoietic stem cell niche: low in oxygen but a nice place 
to be. J. Cell. Physiol. 2010, 222, 17–22. 
[46] Cipolleschi, M. G., Dello Sbarba, P., Olivotto, M., The role of hypoxia in the  maintenance of 
hematopoietic stem  cells. Blood 1993, 82, 2031–2037. 
[47] Busuttil, R. A., Rubio, M., Dolle, M. E., Campisi, J., Vijg, J., Oxygen accelerates the 
accumulation of mutations during  the senescence and immortalization of murine  cells in 
culture.  Aging  Cell 2003, 2, 287–294. 
[48] Schop, D., Janssen, F. W., van Rijn, L. D., Fernandes, H. et al., Growth,  metabolism,  and  
growth  inhibitors  of mesenchymal stem cells. Tissue Eng. Part A 2009, 15, 1877–1886. 
[49] Majmundar, A. J., Wong, W. J., Simon, M. C., Hypoxia-Inducible Fac- tors and the Response 
to Hypoxic Stress. Mol. Cell 2010, 40, 294–309. 
[50] Schop, D., van Dijkhuizen-Radersma, R., Borgart, E., Janssen, F. W., et al., Expansion  of 
human  mesenchymal stromal cells on microcar- riers: growth  and metabolism.  J. Tissue  
Eng. Regen.  Med. 2010, 4, 131–140. 
 
 
 
20 
 
 Table 1. (A) Percentage expression of cell surface markers before passage 1 (0 h) and at the end of passage 4 
(576 h) for all medium exchange conditions at 100% dO2 at saturation. Mean value ± range of data, in all 
cases 10,000 events were measured for duplicate samples. (B) Percentage expression of cell surface markers 
before passage 1 (0 h) and at the end of passage 4 (576 h) for all medium exchange conditions cultured at 
20% dO2 at saturation. Mean value ± range of data, in all cases 10,000 events were measured for duplicate 
samples. 
 
A Immunophenotype 
 
 100% medium 
 
50% medium 
 
0% medium 
   0 h 576 h 576 h 576 h 
 CD29 98.4 ± 0.3 98.2 ± 0.4 98.7 ± 0.6 99.2 ± 0.3 
 CD73 97.1 ± 0.1 97.1 ± 0.4 96.4 ± 0.1 98.2 ± 0.2 
 CD105 99.8 ± 0.1 99.3 ± 0.2 97.6% ± 0.4 98.9 ± 0.2 
 CD34 0.97 ± 0.02 1.5 ± 
 
2.2 ± 0.4 1.2 ± 0.4 
 CD45 0.08 ± 0.02 0.09 ± 0.01 0.18 ± 0.06 0.45 ± 0.1 
 HLA-DR 4.68 ± 0.09 4.44 ± 0.4 4.69 ± 0.3 4.42 ± 0.4 
 
 
B Immunophenotype 
 
 100% medium 
 
50% medium 
 
0% medium 
   0 h 576 h 576 h 576 h 
 CD29 98.4 ± 0.3 97.3 ± 0.4 99.1 ± 0.2 97.9 ± 0.3 
 CD73 97.1 ± 0.1 96.4 ± 0.2 95.6 ± 0.4 97.9 ± 0.3 
 CD105 99.8 ± 0.1 98.9 ± 0.1 99.8% ± 0.1 95.9 ± 0.6 
 CD34 0.97 ± 0.02 0.99 ± 0.03 0.95 ± 0.03 0.98 ± 0.04 
 CD45 0.08 ± 0.02 0.10 ± 0.02 0.11 ± 0.03 0.09 ± 0.00 
 HLA-DR 4.68 ± 0.09 4.29 ± 0.1 4.92 ± 0.2 4.48 ± 0.2 
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Figure 1. Cumulative cell number for (A) 100% dO2 at saturation (20% O2 v/v gas phase) and (B) 20% 
dO2 at saturation (4% O2 v/v gas phase) for 100%, 50% and 0% medium exchange conditions. 
Cumulative population doublings for (C) 100% dO2 at saturation (20% O2 v/v gas phase) and (D) 20% 
dO2 at  saturation (4% O2 v/v gas phase) for 100%, 50% and 0% medium exchange conditions (Mean 
value ± SD, n=4). 
 
 
 
 
 
Figure 2. The effect of medium exchange and dissolved oxygen concentration over four serial passages on 
metabolite consumption and production. Daily medium samples were collected from each experimental 
condition and glucose, lactate and ammonium concentrations measured. Change in glucose con- 
centration for 100% and 20% dO2 for 100% (A), 50% (B) and 0% (C) medium exchange conditions.  
Change in lactate concentration for 100% and 20% dO2 for 100% (D), 50% (E) and 0% (F) medium 
exchange conditions.  Change in ammonium concentration for 100% and 20% dO2 for 100% (G), 50% 
(H) and 0% (I) medium exchange conditions. (Mean value ± SD, n=4). 
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Figure 3. Impact of dO2 concentration (100% dO2 and 20% dO2) and medium exchange (100%, 50% 
and 0%) over four serial passages on (A) Specific growth rate; (B) Fold increase; (C) Doubling time; 
(D) Specific glucose consumption rate; (E) Specific lactate production rate; (F) Yield of lactate from glu- 
cose. 100% dO2 values are on the left hand side of the plot and 20% dO2 values are on the right hand 
side of the plot. 100% medium exchange conditions are represented by the black bars, 50% medium 
exchange conditions  are represented by the grey bars and 0% medium exchange conditions are represent- 
ed by the clear bars. (Data show mean ± SD, n = 4). 
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Figure 4. Immunophenotype  analysis of hMSCs before inoculation  and after passage 4. (A) Flow 
cytometry data displayed are from the 50% medium exchange condition cultured at 20% dO2 at 
saturation. Similar results were obtained for all experimental conditions. Open profiles represent the 
isotype control, filled profiles represent expression of the antibody conjugated cell surface marker. 
Gates are set at 95% of the isotype control. 
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Figure 5. Histology demonstrating  hMSC multipotency  after passage 4. Images displayed are from the 
50% medium exchange condition cultured at 20% dO2 at saturation. Similar results were obtained 
for all experimental conditions. Magnification 10×. (A) Phase-contrast image demonstrating 
osteogenic differentiation of hMSCs after induction with a differentiation-specific medium and 
staining with Alkaline Phosphatase and Von Kossa stains. (B) Phase- contrast image demonstrating 
adipogenic differentiation of hMSCs after induction with a differentiation-specific medium and 
staining with Oil Red O. (C) Phase-contrast image demonstrating chondrogenic differentiation  of 
hMSCs after induction with a differentiation-specific medium and staining with Alcian Blue. 
 
 
 
